cdmo.directory
← Back to posts

CDMO Daily News — November 2, 2026

By BioBM ·

At a glance

Related topics: Manufacturing capacity, Global manufacturing

Lonza Enhances Bioconjugation Manufacturing Capacity in Visp with New Facilities

Operational Impact

The expansion will enhance Lonza's ability to support multiple ADC programs and provide a scalable route to commercial production.

Source: PharmaSource RSS


Cambrex Breaks Ground on $120M Charles City Expansion Adding 160,000 Liters

Operational Impact

Cambrex's Charles City expansion adds 160,000 liters of U.S. small molecule and peptide capacity, which gives outsourcing teams a domestic option for programs moving toward commercial supply, though the capacity arrives only in 4Q28.

Source: Contract Pharma Breaking News RSS


Codis Begins Construction on PSD-4 Spray Drying Expansion at Haverhill, U.K.

Operational Impact

Codis's Haverhill PSD-4 spray dryer adds commercial ASD capacity in the U.K. from Q4 2027, which matters for sponsors planning poorly soluble drug scale-up in that window.

Source: PharmaSource RSS

References

  1. PharmaSource RSS — Lonza Enhances Bioconjugation Manufacturing Capacity in Visp with New Facilities
  2. Contract Pharma Breaking News RSS — Cambrex Breaks Ground on $120M Charles City Expansion Adding 160,000 Liters
  3. PharmaSource RSS — Codis Begins Construction on PSD-4 Spray Drying Expansion at Haverhill, U.K.

Markdown mirror: /posts/daily-news-2026-11-02-cdmo.md